These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23908490)

  • 1. Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis.
    Lahey T; Czechura T; Crabtree S; Arbeit RD; Matee M; Horsburgh CR; MacKenzie T; Bakari M; Pallangyo K; von Reyn CF
    J Infect Dis; 2013 Nov; 208(10):1629-33. PubMed ID: 23908490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.
    Lahey T; Sheth S; Matee M; Arbeit R; Horsburgh CR; Mtei L; Mackenzie T; Bakari M; Vuola JM; Pallangyo K; von Reyn CF
    J Infect Dis; 2010 Oct; 202(8):1265-72. PubMed ID: 20812851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting.
    Theron G; Peter J; Lenders L; van Zyl-Smit R; Meldau R; Govender U; Dheda K
    PLoS One; 2012; 7(5):e37436. PubMed ID: 22629395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.
    Lahey T; Mitchell BK; Arbeit RD; Sheth S; Matee M; Horsburgh CR; MacKenzie T; Mtei L; Bakari M; Vuola JM; Pallangyo K; von Reyn CF
    PLoS One; 2011; 6(7):e22074. PubMed ID: 21799772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.
    Lahey T; Matee M; Mtei L; Bakari M; Pallangyo K; von Reyn CF
    BMC Infect Dis; 2009 Feb; 9():21. PubMed ID: 19236695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.
    Lahey T; Arbeit RD; Bakari M; Horsburgh CR; Matee M; Waddell R; Mtei L; Vuola JM; Pallangyo K; von Reyn CF
    Vaccine; 2010 Nov; 28(48):7652-8. PubMed ID: 20875492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers.
    Van Rie A; Madhi SA; Heera JR; Meddows-Taylor S; Wendelboe AM; Anthony F; Violari A; Tiemessen CT
    Clin Vaccine Immunol; 2006 Feb; 13(2):246-52. PubMed ID: 16467333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
    Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
    Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.
    Vuola JM; Ristola MA; Cole B; Järviluoma A; Tvaroha S; Rönkkö T; Rautio O; Arbeit RD; von Reyn CF
    AIDS; 2003 Nov; 17(16):2351-5. PubMed ID: 14571187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guérin during childhood and entering a tuberculosis booster vaccine trial.
    Matee M; Lahey T; Vuola JM; Mtei L; Cole BF; Bakari M; Arbeit RD; Horsburgh CR; Pallangyo K; von Reyn CF
    J Infect Dis; 2007 Jan; 195(1):118-23. PubMed ID: 17152015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
    Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
    Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
    Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    von Reyn CF; Lahey T; Arbeit RD; Landry B; Kailani L; Adams LV; Haynes BC; Mackenzie T; Wieland-Alter W; Connor RI; Tvaroha S; Hokey DA; Ginsberg AM; Waddell R
    PLoS One; 2017; 12(5):e0175215. PubMed ID: 28498853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    Lahey T; Laddy D; Hill K; Schaeffer J; Hogg A; Keeble J; Dagg B; Ho MM; Arbeit RD; von Reyn CF
    PLoS One; 2016; 11(12):e0168521. PubMed ID: 27997597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.
    Wang C; Chen Z; Fu R; Zhang Y; Chen L; Huang L; Li J; Shi C; Fan X
    Med Microbiol Immunol; 2011 Aug; 200(3):165-75. PubMed ID: 21340709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.